Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02556710 · ClinicalTrials.gov registry record · Phase 3
A Study to Evaluate the Efficacy & Safety of an Intra-Articular Ampion Injection for Pain of Osteoarthritis of the Knee
A Phase 3 study, sponsored by Ampio Pharmaceuticals..
- Completed
- Registry status
- Phase 3
- Development phase
- 480
- Enrollment target
NCT02556710 is a Phase 3 study that has completed, run by Ampio Pharmaceuticals.. The registered enrollment target is 480 participants.
The verdict
NCT02556710, a Phase 3 study, has completed, sponsored by Ampio Pharmaceuticals..
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 480 participants
- Enrollment target
Study Summary
This study will evaluate the efficacy and safety of an intra-articular injection of AMPION™ in adults with pain due to osteoarthritis of the knee
Interventions
- DRUG 4 mL injection of Placebo
- BIOLOGICAL 4 mL injection of AMPION™
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 480 participants |
| Start Date | 2015-09 |
| Est. Completion | 2016-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02556710
The ClinicalTrials.gov registry entry for NCT02556710 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 480 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ampio Pharmaceuticals., which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 4 mL injection of Placebo is the first listed.
NCT02556710 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02556710 about?
NCT02556710 is a clinical study titled "A Study to Evaluate the Efficacy & Safety of an Intra-Articular Ampion Injection for Pain of Osteoarthritis of the Knee". This study will evaluate the efficacy and safety of an intra-articular injection of AMPION™ in adults with pain due to osteoarthritis of the knee
What is the current status of trial NCT02556710?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 480 participants. The study started on 2015-09. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02556710?
The interventions under investigation include: 4 mL injection of Placebo (DRUG), 4 mL injection of AMPION™ (BIOLOGICAL).
Who is sponsoring clinical trial NCT02556710?
This trial is sponsored by Ampio Pharmaceuticals., which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.